Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial

Table 4

BPV-the other parameters.

	Valsartan			Fimasartan
S.D.	Initial	8 weeks	P-value	Initial	8 weeks	P-value
24-h SBP wSD	8.88±3.55	10.77±4.18	.038	10.26±3.19	8.27±3.01	.013
24-h DBP wSD	6.74±2.82	7.84±2.71	.066	7.29±2.91	6.82±2.72	.518
24-h SBP CV	10.95±4.50	15.51±6.91	.003	13.76±4.25	13.47±4.21	.769
24-h DBP CV	14.24±5.48	19.05±7.82	.004	16.58±6.09	18.02±5.98	.352
24-h SBP ARV	17.77±7.01	19.68±7.83	.244	18.23±4.20	15.85±6.17	.101
24-h DBP ARV	14.20±5.79	15.44±6.82	.326	14.15±4.60	13.82±6.00	.790

Values are presented as the mean ± SD. P values were calculated using the paired t-test.